DASATINIB (SPRYCEL) AND ERLOTINIB (TARCEVA) FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA: A PHASE 1 TRIAL
Published
Conference Paper
Full Text
Duke Authors
Cited Authors
- Desjardins, A; Peters, KB; Vredenburgh, JJ; Friedman, HS; Reardon, DA
Published Date
- November 1, 2010
Published In
Volume / Issue
- 12 /
Start / End Page
- 51 - 51
Published By
Pages
- 1
International Standard Serial Number (ISSN)
- 1522-8517
Conference Name
- Advances in Inflammatory Bowel Diseases Crohns and Colitis Foundations National Clinical and Research Conference
Conference Location
- Hollywood, FL
Conference Start Date
- December 9, 2010
Conference End Date
- December 12, 2010